Related Experiment Video
Updated: May 8, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly
Lidia Glodzik1, Henry Rusinek, Elizabeth Pirraglia
1Department of Psychiatry, Center for Brain Health, New York University School of Medicine, New York, NY, USA; Department of Radiology, New York University School of Medicine, New York, NY, USA.
Insights
Hypertension (HTN) may make individuals sensitive to blood pressure (BP) reductions, potentially impacting memory and Alzheimer's biomarkers. Lowering BP in those with HTN requires careful consideration due to increased brain vulnerability.
Area of Science:
- Neurology
- Gerontology
- Cardiovascular Science
Background:
- Hypertension (HTN) alters cerebral blood flow regulation, potentially increasing brain vulnerability to reduced blood pressure (BP).
- Cognitively healthy elderly individuals with HTN may have a higher threshold for safe BP maintenance.
- The impact of longitudinal BP changes on Alzheimer's disease (AD) biomarkers in this population is not fully understood.
Purpose of the Study:
- To investigate the relationship between changes in mean arterial pressure (MAP) and cerebrospinal fluid (CSF) biomarkers of AD.
- To examine the association of MAP changes with memory decline and hippocampal atrophy.
- To determine if these relationships differ between individuals with and without HTN.
Main Methods:
- Longitudinal study of 77 cognitively healthy elderly subjects (25 with HTN) assessed twice over approximately 2 years.
- Evaluations included medical history, neuropsychological testing, lumbar puncture for CSF biomarkers, and magnetic resonance imaging (MRI).
- Analysis focused on changes in MAP, CSF phosphorylated tau (p-tau(181)), verbal episodic memory, and hippocampal volume (HipV).
Main Results:
- No baseline differences in CSF biomarkers, HipV, or memory scores between hyper- and normotensive groups.
- Increased p-tau(181) correlated with memory decline and HipV reduction in the overall group.
- A longitudinal decrease in MAP was significantly associated with memory decline and increased p-tau(181) specifically in the hypertensive group.
Conclusions:
- The hypertensive group demonstrated sensitivity to BP reductions, linking decreased MAP to cognitive decline and AD biomarker changes.
- Findings suggest that hypertensive individuals may be more vulnerable to the effects of lowered BP on brain health.
- Further research is needed to understand the clinical implications of BP management in hypertensive elderly individuals concerning cognitive function and AD pathology.
Abstract:
In hypertension (HTN), cerebral blood flow regulation limits are changed, and the threshold for blood pressure (BP) at which perfusion is safely maintained is higher. This shift may increase the brain's vulnerability to lower BP in subjects with vascular disease. We investigated whether longitudinal reduction in mean arterial pressure (MAP) was related to changes in cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease in a group of cognitively healthy elderly with and without HTN. The relationships among MAP, memory decline, and hippocampal atrophy were also examined. Seventy-seven subjects (age 63.4 ± 9.4, range 44-86 years; education 16.9 ± 2.1, range 10-22 years; 60% women) were assessed twice, 2 ± 0.5 years apart. At both time points, all subjects underwent full medical and neuropsychological evaluations, lumbar punctures, and magnetic resonance imaging examinations. Twenty-five subjects had HTN. Hyper- and normotensive subjects did not differ in their CSF biomarkers, hippocampal volumes (HipVs), or memory scores at baseline. In the entire study group, the increase in tau phosphorylated at threonine 181 (p-tau(181)) was associated with a decline in verbal episodic memory (β = -0.30, p = 0.01) and HipV reduction (β = -0.27, p = 0.02). However, longitudinal decrease in MAP was related to memory decline (β = 0.50, p = 0.01) and an increase in p-tau(181) (β = -0.50, p = 0.01) only in subjects with HTN. Our findings suggest that the hypertensive group may be sensitive to BP reductions.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Alzheimer Disease ll: Pathophysiology
Factors affecting Blood pressure
Physiological Factors:

